Clinical Trial Update: Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer [Phase 2]

View source ↗

Summary

BeiGene's Phase 2 study of BGB-290 versus placebo in advanced or inoperable gastric cancer has completed, with results posted in September 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• BGB-290

Snippet

Sponsor: BeiGene | Conditions: Advanced or Inoperable Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-09-21